Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: A single dose study
- 1 April 1985
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 6 (2) , 131-137
- https://doi.org/10.1002/bdd.2510060204
Abstract
The pharmacokinetics of acebutolol and its major metabolite, diacetolol, following a single 400 mg oral dose, were investigated in patients with liver disease. No significant differences were found in any of the parameters measured.Keywords
This publication has 15 references indexed in Scilit:
- A Pharmacokinetic Study of Acebutolol in Aged Subjects as Compared to Young SubjectsGerontology, 1983
- Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of manJournal of Pharmacy and Pharmacology, 1981
- Reduction of Liver Blood Flow and Propranolol Metabolism by CimetidineNew England Journal of Medicine, 1981
- Cimetidine Impairs Elimination of Chlordiazepoxide (Librium) in ManAnnals of Internal Medicine, 1980
- CIMETIDINE: INTERACTION WITH ORAL ANTICOAGULANTS IN MANThe Lancet, 1979
- High-pressure liquid chromatographic analysis of drugs in biological fluidsJournal of Chromatography A, 1977
- Determinants of response to frusemide in normal subjects.British Journal of Clinical Pharmacology, 1977
- The biliary excretion of acebutolol in manJournal of Pharmacy and Pharmacology, 1976
- Interactions between oral Yvonne contraceptives and other drugs: a reviewCurrent Medical Research and Opinion, 1976
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975